"New Molecular Drivers Of Parkinson’s Disease Uncovered"
Researchers at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson’s disease using a sophisticated statistical technique called multiscale gene network analysis (MGNA) and were able to determine how these molecular drivers impact the functions of genes involved in the disease. The results may point to potential new treatments. “This study offers a novel approach to understanding the majority of cases of Parkinson’s,” said Bin Zhang, PhD, professor of genetics and genomic sciences at the Icahn Institute for Data Science and Genomic Technology. “The work opens up a new avenue for studying the disease,” said Zhenyu Yue, PhD, professor of neurology and neuroscience at the Icahn School of Medicine at Mount Sinai.
— Zhenyu Yue, PhD, Professor, Neurology, Neuroscience, Director, Translational Research of Movement Disorders, Icahn School of Medicine at Mount Sinai
— Bin Zhang, PhD, Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
Additional coverage: Genetic Engineering & Biotechnology News Online; Health Medicine Network
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases
Scientists Show How Bone-Bordering Cells May Help Shape a Skull
Dec 09, 2021 View All Press ReleasesMount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
Nov 20, 2019 View All Press Releases